Fabrice Barlesi

Professor Fabrice Barlesi is a leading specialist in lung cancer, precision medicine, and cancer immunology. Currently serving as the General Director of Gustave Roussy since August 2021 and Professor of Medicine at Paris Saclay University, he has pioneered research in innovative oncological therapies and resistance to immunotherapy (anti-PD1/L1). His career spans leadership roles in clinical research, including founding the Marseille Centre for Early Trials in Oncology (CLIP2) and co-founding the Marseille Immunopôle, a French immunology cluster.

Education:

• Doctorate in Sciences and Management (healthcare systems analysis)
• Master’s degree in General Hospital Management from ESSEC

Research Focus centers on advancing precision oncology, overcoming immunotherapy resistance, and coordinating international clinical trials like PIONeeR. His work bridges translational research, clinical practice, and multidisciplinary innovation in cancer treatment.

Scientific Awards

• Heine H. Hansen Prize (ESMO/IASLC, 2018)
• Daniel C Ihde Prize
• Web of Science Group Highly Cited Researcher (2024)

With over 400 publications, he drives collaborative networks such as Cancer Core Europe and PACA Region Cancer Research Directorate, integrating academia, hospitals, and industry to transform cancer care.